IPHA

Innate Pharma S.A. is a French biotechnology company developing immunotherapies for cancer treatment. The company focuses on harnessing the innate immune system, particularly natural killer (NK) cells, to fight tumors. Innate Pharma's pipeline includes antibody-based therapies targeting various immune checkpoints and tumor-associated antigens. The company collaborates with major pharmaceutical partners including AstraZeneca and Sanofi to develop and commercialize its innovative immunotherapy candidates.